Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMissing a Wegovy dose does not usually cause dramatic side effects, but it can trigger a temporary return of hunger and, in some people, mild nausea when the next dose is taken. The most important thing to know is what to do next — and what not to do. Wegovy (semaglutide) is a prescription-only medicine, and any questions about your specific schedule should be discussed with your prescriber. The NHS semaglutide page and the Patient Information Leaflet supplied with your pen are the two most reliable references for dose-timing guidance. This page covers what the evidence says, the common misconceptions, and the signs that genuinely need medical attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common worry people share is that skipping even one injection wipes out weeks of progress and forces the body back to square one. That is not how semaglutide works. Wegovy has a half-life of roughly one week, meaning meaningful levels of the medicine remain in your system for several days after a missed injection. Weight loss does not simply switch off. What many people do notice is that appetite returns more quickly than usual, sometimes within a few days of the gap. That is the medicine's concentration falling, not your biology going into reverse.
Hunger coming back can feel alarming, especially if you have spent weeks adjusting to smaller portions. Acknowledging that this is a real and understandable experience matters. It does not mean treatment has failed. For practical guidance on timing and what to do when a dose slips, the full guide on missing a Wegovy dose covers the specific windows in detail.
The broader picture of how Wegovy works and what to expect across the full titration schedule is covered on the Wegovy doses page, which is worth reading if you are still in the early weeks of treatment.
A missed dose itself rarely causes direct side effects. The more common scenario is that resuming after a gap (particularly if several days have passed) brings a brief wave of the gastrointestinal symptoms that are most common at the start of treatment: nausea, loose stools, reflux, or a sense of fullness after very small amounts of food. These tend to be mild and settle within a day or two as the medicine re-establishes its level in your system.
The risk is higher if you missed multiple consecutive doses. Semaglutide's effects on gastric emptying are partly responsible for early-dose nausea, and a restart after a longer gap can feel similar to beginning the medicine afresh. Staying well hydrated and eating small, bland meals in the day or two after resuming can help. The side effects associated with the 0.25mg starting dose give a useful reference point for what a restart-style response can look like.
If you want to understand how side effects vary across the titration journey, the 0.5mg side effect profile and the 2.4mg maintenance dose experience cover those stages separately.
Most side effects after a missed or resumed dose are mild and short-lived. But some symptoms should not be waited out at home. Get medical help promptly if you experience:
If in doubt, call NHS 111. For less urgent concerns, your prescriber is the right first contact. You can also report any suspected side effects (whether or not you think they are serious) to the MHRA via the Yellow Card scheme. Reports from patients are genuinely useful and help regulators monitor medicines in real-world use.
Wegovy is injected once a week, and the schedule matters. The five-day rule is the key reference point: if you remember a missed dose within five days of when it was due, take it and then return to your usual day the following week. If more than five days have passed (say you forgot over a bank holiday, or a late payday meant your prescription arrived after a gap) skip the missed injection entirely and simply resume on your normal day. Never take two doses in the same week to compensate.
Life gets in the way. A prescriber who hears this question regularly will tell you that bank holidays, busy weeks and delayed deliveries are among the most common reasons people miss a dose. It happens, and one missed injection is manageable. What creates more difficulty is missing several weeks and then restarting at the same dose without prescriber input; in that situation, your clinical team may recommend dropping back a step. That decision belongs with the prescriber, not a forum or a best guess.
If you are considering Wegovy or want to understand the full treatment journey, the Wegovy overview page covers the medicine from scratch. Those ready to discuss suitability can speak to our prescribers through a free consultation, where side effects, your current schedule and any concerns are part of the conversation from the start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.